Immunic is trading at $9.76 (-10.01%) after reversing lower during the September 23, 2026 session; the specific catalyst remains unclear.
- No new company-specific announcement dated September 23 was identified on Immunic’s official news page.
- The broader biotech sector is higher, so sector strength does not explain the decline.
- Macro weakness may be contributing, but evidence is insufficient to establish causation.